-
Utilization of informatics for integrating biology and the bedside to access preliminary outcome data of post-operative complication of spine surgery associated with diabetes mellitus
Tomoko Tanaka, Abu Saleh Mohammad Mosa, N Scott Litofsky
Research Article: Clinical Investigation
-
Utilization of informatics for integrating biology and the bedside to access preliminary outcome data of post-operative complication of spine surgery associated with diabetes mellitus
Tomoko Tanaka, Abu Saleh Mohammad Mosa, N Scott Litofsky
Research Article: Clinical Investigation
-
Utilization of informatics for integrating biology and the bedside to access preliminary outcome data of post-operative complication of spine surgery associated with diabetes mellitus
Tomoko Tanaka, Abu Saleh Mohammad Mosa, N Scott Litofsky
Research Article: Clinical Investigation
-
Utilization of informatics for integrating biology and the bedside to access preliminary outcome data of post-operative complication of spine surgery associated with diabetes mellitus
Tomoko Tanaka, Abu Saleh Mohammad Mosa, N Scott Litofsky
Research Article: Clinical Investigation
-
Utilization of informatics for integrating biology and the bedside to access preliminary outcome data of post-operative complication of spine surgery associated with diabetes mellitus
Tomoko Tanaka, Abu Saleh Mohammad Mosa, N Scott Litofsky
Research Article: Clinical Investigation
-
Utilization of informatics for integrating biology and the bedside to access preliminary outcome data of post-operative complication of spine surgery associated with diabetes mellitus
Tomoko Tanaka, Abu Saleh Mohammad Mosa, N Scott Litofsky
Research Article: Clinical Investigation
-
Telotristat etiprate, a novel inhibitor of serotonin synthesis for the treatment of carcinoid syndrome
Pablo Lapuerta, Brian Zambrowicz, Doug Fleming, Darren Wheeler & Arthur Sands
Special Report: Clinical Investigation
-
Telotristat etiprate, a novel inhibitor of serotonin synthesis for the treatment of carcinoid syndrome
Pablo Lapuerta, Brian Zambrowicz, Doug Fleming, Darren Wheeler & Arthur Sands
Special Report: Clinical Investigation
-
Telotristat etiprate, a novel inhibitor of serotonin synthesis for the treatment of carcinoid syndrome
Pablo Lapuerta, Brian Zambrowicz, Doug Fleming, Darren Wheeler & Arthur Sands
Special Report: Clinical Investigation
-
Telotristat etiprate, a novel inhibitor of serotonin synthesis for the treatment of carcinoid syndrome
Pablo Lapuerta, Brian Zambrowicz, Doug Fleming, Darren Wheeler & Arthur Sands
Special Report: Clinical Investigation
-
Telotristat etiprate, a novel inhibitor of serotonin synthesis for the treatment of carcinoid syndrome
Pablo Lapuerta, Brian Zambrowicz, Doug Fleming, Darren Wheeler & Arthur Sands
Special Report: Clinical Investigation
-
Telotristat etiprate, a novel inhibitor of serotonin synthesis for the treatment of carcinoid syndrome
Pablo Lapuerta, Brian Zambrowicz, Doug Fleming, Darren Wheeler & Arthur Sands
Special Report: Clinical Investigation
-
Vinflunine for the treatment of metastatic transitional cell carcinoma: recent evidence from clinical trials and observational studies
Camille Serrate, Damien Pouessel, Helene Gauthier, Christine le Maignan, Luis Teixeira & Stephane Culine
Review: Clinical Trail Outcomes: Clinical Investigation
-
Vinflunine for the treatment of metastatic transitional cell carcinoma: recent evidence from clinical trials and observational studies
Camille Serrate, Damien Pouessel, Helene Gauthier, Christine le Maignan, Luis Teixeira & Stephane Culine
Review: Clinical Trail Outcomes: Clinical Investigation
-
Vinflunine for the treatment of metastatic transitional cell carcinoma: recent evidence from clinical trials and observational studies
Camille Serrate, Damien Pouessel, Helene Gauthier, Christine le Maignan, Luis Teixeira & Stephane Culine
Review: Clinical Trail Outcomes: Clinical Investigation
-
Vinflunine for the treatment of metastatic transitional cell carcinoma: recent evidence from clinical trials and observational studies
Camille Serrate, Damien Pouessel, Helene Gauthier, Christine le Maignan, Luis Teixeira & Stephane Culine
Review: Clinical Trail Outcomes: Clinical Investigation
-
Vinflunine for the treatment of metastatic transitional cell carcinoma: recent evidence from clinical trials and observational studies
Camille Serrate, Damien Pouessel, Helene Gauthier, Christine le Maignan, Luis Teixeira & Stephane Culine
Review: Clinical Trail Outcomes: Clinical Investigation
-
Vinflunine for the treatment of metastatic transitional cell carcinoma: recent evidence from clinical trials and observational studies
Camille Serrate, Damien Pouessel, Helene Gauthier, Christine le Maignan, Luis Teixeira & Stephane Culine
Review: Clinical Trail Outcomes: Clinical Investigation
-
The nocebo effect: should we be worried?
Luana Colloca
Editorial: Clinical Investigation
-
The nocebo effect: should we be worried?
Luana Colloca
Editorial: Clinical Investigation
-
The nocebo effect: should we be worried?
Luana Colloca
Editorial: Clinical Investigation
-
The nocebo effect: should we be worried?
Luana Colloca
Editorial: Clinical Investigation
-
The nocebo effect: should we be worried?
Luana Colloca
Editorial: Clinical Investigation
-
The nocebo effect: should we be worried?
Luana Colloca
Editorial: Clinical Investigation
-
New advances in the diagnosis and treatment of pediatric tuberculosis
Andrea T Cruz, Anna M Mandalakas
Review: Clinical Trail Outcomes: Clinical Investigation
-
New advances in the diagnosis and treatment of pediatric tuberculosis
Andrea T Cruz, Anna M Mandalakas
Review: Clinical Trail Outcomes: Clinical Investigation
-
New advances in the diagnosis and treatment of pediatric tuberculosis
Andrea T Cruz, Anna M Mandalakas
Review: Clinical Trail Outcomes: Clinical Investigation
-
New advances in the diagnosis and treatment of pediatric tuberculosis
Andrea T Cruz, Anna M Mandalakas
Review: Clinical Trail Outcomes: Clinical Investigation
-
New advances in the diagnosis and treatment of pediatric tuberculosis
Andrea T Cruz, Anna M Mandalakas
Review: Clinical Trail Outcomes: Clinical Investigation
-
New advances in the diagnosis and treatment of pediatric tuberculosis
Andrea T Cruz, Anna M Mandalakas
Review: Clinical Trail Outcomes: Clinical Investigation
-
Bioabsorbable stents-nothing from something
NS Rajendra, BJ Wrigley, AH Gershlick
Special Report: Clinical Investigation
-
Bioabsorbable stents-nothing from something
NS Rajendra, BJ Wrigley, AH Gershlick
Special Report: Clinical Investigation
-
Bioabsorbable stents-nothing from something
NS Rajendra, BJ Wrigley, AH Gershlick
Special Report: Clinical Investigation
-
Bioabsorbable stents-nothing from something
NS Rajendra, BJ Wrigley, AH Gershlick
Special Report: Clinical Investigation
-
Bioabsorbable stents-nothing from something
NS Rajendra, BJ Wrigley, AH Gershlick
Special Report: Clinical Investigation
-
Bioabsorbable stents-nothing from something
NS Rajendra, BJ Wrigley, AH Gershlick
Special Report: Clinical Investigation
-
Overcoming the logistics of immune monitoring of cancer patients during clinical trials
Marc S Ernstoff
Editorial: Clinical Investigation
-
Overcoming the logistics of immune monitoring of cancer patients during clinical trials
Marc S Ernstoff
Editorial: Clinical Investigation
-
Overcoming the logistics of immune monitoring of cancer patients during clinical trials
Marc S Ernstoff
Editorial: Clinical Investigation
-
Overcoming the logistics of immune monitoring of cancer patients during clinical trials
Marc S Ernstoff
Editorial: Clinical Investigation
-
Overcoming the logistics of immune monitoring of cancer patients during clinical trials
Marc S Ernstoff
Editorial: Clinical Investigation
-
Overcoming the logistics of immune monitoring of cancer patients during clinical trials
Marc S Ernstoff
Editorial: Clinical Investigation
-
New considerations in the design of clinical trials for traumatic brain injury
Bob Roozenbeek, Hester F Lingsma Andrew I R Maas
Clinical Trail Methodology: Clinical Investigation
-
New considerations in the design of clinical trials for traumatic brain injury
Bob Roozenbeek, Hester F Lingsma Andrew I R Maas
Clinical Trail Methodology: Clinical Investigation
-
New considerations in the design of clinical trials for traumatic brain injury
Bob Roozenbeek, Hester F Lingsma Andrew I R Maas
Clinical Trail Methodology: Clinical Investigation
-
New considerations in the design of clinical trials for traumatic brain injury
Bob Roozenbeek, Hester F Lingsma Andrew I R Maas
Clinical Trail Methodology: Clinical Investigation
-
New considerations in the design of clinical trials for traumatic brain injury
Bob Roozenbeek, Hester F Lingsma Andrew I R Maas
Clinical Trail Methodology: Clinical Investigation
-
New considerations in the design of clinical trials for traumatic brain injury
Bob Roozenbeek, Hester F Lingsma Andrew I R Maas
Clinical Trail Methodology: Clinical Investigation
-
Clinical evidence for the role of pixantrone in the treatment of relapsed or refractory aggressive non-Hodgkins lymphoma
Anne W Beaven , David Rizzieri
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of pixantrone in the treatment of relapsed or refractory aggressive non-Hodgkins lymphoma
Anne W Beaven , David Rizzieri
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of pixantrone in the treatment of relapsed or refractory aggressive non-Hodgkins lymphoma
Anne W Beaven , David Rizzieri
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of pixantrone in the treatment of relapsed or refractory aggressive non-Hodgkins lymphoma
Anne W Beaven , David Rizzieri
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of pixantrone in the treatment of relapsed or refractory aggressive non-Hodgkins lymphoma
Anne W Beaven , David Rizzieri
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of pixantrone in the treatment of relapsed or refractory aggressive non-Hodgkins lymphoma
Anne W Beaven , David Rizzieri
Review: Clinical Trail Outcomes: Clinical Investigation
-
Assessment of neuropathic pain in the setting of intervention trials
Nadine Attal
Review Article: Clinical Investigation
-
Assessment of neuropathic pain in the setting of intervention trials
Nadine Attal
Review Article: Clinical Investigation
-
Assessment of neuropathic pain in the setting of intervention trials
Nadine Attal
Review Article: Clinical Investigation
-
Assessment of neuropathic pain in the setting of intervention trials
Nadine Attal
Review Article: Clinical Investigation
-
Assessment of neuropathic pain in the setting of intervention trials
Nadine Attal
Review Article: Clinical Investigation
-
Assessment of neuropathic pain in the setting of intervention trials
Nadine Attal
Review Article: Clinical Investigation
-
Sodium,glucose cotransporter 2 inhibitors in the treatment of Type 2 diabetes: a review of Phase II and III trials
Mark S Kipnes
Review Article: Clinical Investigation
-
Sodium,glucose cotransporter 2 inhibitors in the treatment of Type 2 diabetes: a review of Phase II and III trials
Mark S Kipnes
Review Article: Clinical Investigation
-
Sodium,glucose cotransporter 2 inhibitors in the treatment of Type 2 diabetes: a review of Phase II and III trials
Mark S Kipnes
Review Article: Clinical Investigation
-
Sodium,glucose cotransporter 2 inhibitors in the treatment of Type 2 diabetes: a review of Phase II and III trials
Mark S Kipnes
Review Article: Clinical Investigation
-
Sodium,glucose cotransporter 2 inhibitors in the treatment of Type 2 diabetes: a review of Phase II and III trials
Mark S Kipnes
Review Article: Clinical Investigation
-
Sodium,glucose cotransporter 2 inhibitors in the treatment of Type 2 diabetes: a review of Phase II and III trials
Mark S Kipnes
Review Article: Clinical Investigation